
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES63
Nateglinide in combination with metformin was compared with gliclazide and metformin, to
compare the effects on glycaemic control in patients with Type 2 diabetes: no significant difference was seen between the groups in terms of HbA1c  the nateglinide group demonstrated better PPG control.

[@Ristic_2006]

